What is the level of liabilities of TELA Bio this year?
TELA Bio has a debt balance of 59.17 M USD this year.
TELA Bio Liabilities 2024
TELA Bio Liabilities
59.17 M USD
TELA Bio Dividend yield
Ticker
TELA
ISIN
US8723811084
WKN
A2PUP9
In 2024, TELA Bio's total liabilities amounted to 59.17 M USD, a 10.49% difference from the 53.55 M USD total liabilities in the previous year.
TELA Bio Aktienanalyse
What does TELA Bio do?
TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing TELA Bio's Liabilities
TELA Bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating TELA Bio's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing TELA Bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
TELA Bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in TELA Bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about TELA Bio Stock
What were the liabilities of TELA Bio compared to the previous year?
The liabilities of TELA Bio have increased by 10.49% increased compared to the previous year.
What are the consequences of high debt for investors of TELA Bio?
High liabilities can pose a risk for investors of TELA Bio, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in TELA Bio?
Low liabilities mean that TELA Bio has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of TELA Bio affect the company?
An increase in liabilities of TELA Bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of TELA Bio affect the company?
A decrease in the liabilities of TELA Bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of TELA Bio?
Some factors that can influence the liabilities of TELA Bio include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of TELA Bio so important for investors?
The liabilities of TELA Bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can TELA Bio take to modify the liabilities?
To change its liabilities, TELA Bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does TELA Bio pay?
Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of TELA Bio?
The current dividend yield of TELA Bio is .
When does TELA Bio pay dividends?
TELA Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of TELA Bio?
TELA Bio paid dividends every year for the past 0 years.
What is the dividend of TELA Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is TELA Bio located?
TELA Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of TELA Bio from 5/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.
When did TELA Bio pay the last dividend?
The last dividend was paid out on 5/28/2024.
What was the dividend of TELA Bio in the year 2023?
In the year 2023, TELA Bio distributed 0 USD as dividends.
In which currency does TELA Bio pay out the dividend?
The dividends of TELA Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von TELA Bio
Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
